Chih-Yeh Tu

Comparing the effects of afatinib with gefitinib or Erlotinib in patients with advanced-stage lung adenocarcinoma harboring non-classical epidermal growth factor receptor mutations

Yi-Cheng Shen, Guan-Chin Tseng, Chih-Yeh Tu et al. · Lung Cancer · 2017 · 98 citations

Medicine, Oncology, Pharmacology +12

The modified SAVE score: predicting survival using urgent veno-arterial extracorporeal membrane oxygenation within 24 hours of arrival at the emergency department

Wei-Cheng Chen, Kuo‐Yang Huang, Chih-Wei Yao et al. · Critical Care · 2016 · 96 citations · Full text

Medicine, Emergency Medical Services, Emergency Medicine +17

Inaccuracy of lung adenocarcinoma subtyping using preoperative biopsy specimens

Pin-Zuo Ko, Chih-Wei Yao, Cheng-Nan Hsu et al. · Journal of Thoracic and Cardiovascular Surgery · 2017 · 55 citations · Full text

Medicine, Oncology, Surgery +14